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Thoracoabdominal aortic aneurysm repair: 
current endovascular perspectives
Nathan Orr
David Minion
Joseph L Bobadilla
Vascular and endovascular  
Surgery, Department of Surgery,  
University of Kentucky, Lexington,  
KY, USA
Abstract: Thoracoabdominal aneurysms account for roughly 3% of identified aneurysms 
annually in the United States. Advancements in endovascular techniques and devices have broad-
ened their application to these complex surgical problems. This paper will focus on the current 
state of endovascular thoracoabdominal aneurysm repair, including specific considerations in 
patient selection, operative planning, and perioperative complications. Both total endovascular 
and hybrid options will be considered.
Keywords: thoracoabdominal aneurysm, thoracic aorta, TEVAR, endovascular surgery
Introduction
Aneurysms of the thoracoabdominal aorta (TAAs) are relatively uncommon in the 
spectrum of aneurysmal disease, accounting for only 3% of diagnosed aneurysms in 
the United States (US).1 This results in roughly ten new aneurysms per 100,000 person-
years.2,3 The initial classification schema for TAAs was described in 1986 by  Crawford 
and Coselli.4 This included four subtypes of varying extent of the thoracic and abdomi-
nal aorta. In 1999 Safi and Miller modified the initial Crawford classification by adding 
a fifth subtype (Figure 1).5 Both female sex and the presence of Chronic Obstructive 
Pulmonary Disease (COPD) have been associated with increased risk of rupture. 
While female sex has been associated with delayed time to aneurysm formation, the 
absolute risk of rupture is increased in size for size match cohorts. COPD has been 
associated with a 3.6-fold higher risk of rupture.6 Longitudinal studies have shown 
that for every 1 cm growth over 5 cm, the risk of rupture doubles.6 Untreated, nearly 
80% will progress to rupture.7 At 6–6.5 cm, that annualized risk of rupture is roughly 
7%; as such, this is often the threshold for intervention.8
The first published reports of TAA repair were in 1955 by Etheredge et al and 
Rob.9,10 These aneurysms were approached via a left lateral thoracoabdominal inci-
sion and included  reconstruction of the visceral segment of the abdominal aorta. 
Two years prior to this, De Bakey and Cooley reported their experience with isolated 
thoracic aortic  aneurysms.11 Over the next 10 years, they amassed 42 patients who 
underwent repair utilizing Dacron interposition grafts.12 In 1974, E Stanley Crawford 
reported his  experience with visceral pedicles, including en bloc anastomosis of the 
celiac, superior mesenteric artery (SMA), and right renal, followed by isolated left 
renal  reimplantation.13 Despite improvements in operative technique and anesthetic 
support, operative mortality after open repair continues to range from 3% to 8%.14 
Strategies for aneurysm repair took a drastic deviation with the initial descriptions 
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of  transfemoral treatment in 1991.15 Continued efforts to 
expand the use of this technology and reduce morbidity 
and mortality of TAA repair led to the first endovascular 
exclusion reported in 1994.16 The US Food and Drug 
Administration (FDA) approved the first thoracic endograft 
in 2005. Current endovascular techniques include debranch-
ing procedures whereby proximal or distal  landing zones 
are created by the construction of extra-anatomic bypass to 
either visceral or arch vessels.17 Another common approach 
includes the utilization of chimneys, or snorkels, to pre-
serve flow to side branch vessels.18 Both represent viable 
options in the absence of more mature endovascular devices. 
With the recent availability of fenestrated and side branch 
devices, the envelope of totally endovascular TAA repair has 
again been pushed.19 Unfortunately, many of these devices 
require custom fabrication, resulting in a delay of many 
weeks until treatment can be delivered. Ultimately, the total 
endovascular repair of complex TAAs will depend on the 
availability of a usable, modular, off-the-shelf device.20 In 
this paper, we will review the current state of endovascular 
TAA repair technology, including hybrid solutions and 
total endovascular treatment options for this complex and 
challenging disease.
Patient selection and evaluation
Elefteriades and Botta have nicely outlined guidelines for 
intervention for TAAs in their recent publication (Table 1).21 
These indications include: 1) rupture, 2) acute  dissection, 
3) persistent symptomatic state, 4) rapid growth, and 
5)  absolute size criterion. In the urgent and emergent set-
ting, one does not have the luxury of a complete preopera-
tive evaluation and risk factor management; however, in the 
elective patients, a standardized work-up for aortic surgery 
should be completed. This should include pulmonary, cardiac, 
and renal evaluations. Pre-existing renal insufficiency has 
been shown to be an independent predictor for postopera-
tive morbidity and mortality in multiple studies.22–24 With 
the added use of nephrotoxic contrast agents essential to 
endovascular procedures, this common comorbidity becomes 
even more important. In addition, patients may also undergo 
spinal magnetic resonance angiography (MRA) to identify 
important intercostal arteries to attempt to salvage during 
I II III IV V
6th 6th
Figure 1 Thoracoabdominal aneurysm classification.
Notes: Type i extends from the left subclavian artery to the celiac axis. Type ii extends from the left subclavian artery and includes the infrarenal abdominal aorta to the level 
of the aortic bifurcation. Type iii extends from the sixth intercostal space to the iliac bifurcation. Type iV extends from the visceral abdominal aorta to the iliac bifurcation. 
Type V extends from the sixth intercostal space to just above the renal arteries. Reprinted from The Annals of Thoracic Surgery, 67(6), Safi HJ, Miller CC 3rd, Spinal cord 
protection in descending thoracic and thoracoabdominal aortic repair, 1937–1939, Copyright © 1999, with permission from elsevier.5
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long segment coverage.25 If possible, staged repair has been 
shown to reduce the incidence of postoperative paraplegia, 
by allowing collateral pathways to the anterior spinal artery 
to mature during serial interventions.26,27 Computed tomo-
graphic angiography of the aorta and branch vessels with 
three-dimensional reconstruction and postprocessing image 
manipulation software are essential tools when advanced 
endovascular techniques are being utilized.28 True centerline 
measurements and multiplanar reconstructions are essen-
tial in the accurate evaluation and planning, including the 
evaluation of proximal and distal landing zones, the degree 
of aortic tortuosity, the relationship of the aneurysm to arch 
and visceral branch vessels, and the size and quality of the 
access vessels.
Complications
Complications associated with thoracoabdominal thoracic 
endovascular aneurysm repair (TEVAR) include stroke 
(3%–5%), paraplegia (up to 6%), access site complica-
tions (6%–14%), endoleaks (9%–38%), device migration 
(0.7%–3.9%), graft collapse (rare), and persistent aneurysm 
sac enlargement (7.1%–14.5%).29–36 As teams progress along 
the learning curve and gain experience with preoperative 
planning and graft deployment techniques, the rates of these 
complications tend to diminish.
Renal failure and contrast- 
induced nephropathy
A 2006 review of contrast-induced nephropathy (CIN) 
 estimated the risk of CIN to be between 8%–14.5%.37 While 
the risk of CIN is clearly linked to the amount of contrast 
and pre-existing renal function, there is a very real risk of 
precipitous renal function decline and potential dialysis in 
any patient with a multitude of risk factors. These risk factors 
include diabetes, age over 75 years, periprocedural volume 
depletion, heart failure, cirrhosis or ne phrosis, hypertension, 
proteinuria, recent use of nonsteroidal anti-inflammatory 
drugs, and intra-arterial injection of contrast as opposed to 
intravenous.37,38 Many of these risk factors are present in 
our TEVAR populations. With the increasing complexity of 
cases treated via endovascular techniques, contrast utilization 
increases as well. As such, we must employ careful and con-
scious strategies to decrease the volume of these nephrotoxic 
agents, both intraoperatively and postoperatively.39
Cerebrovascular accidents
Neurological complications, including stroke and spinal cord 
ischemia, still remain one of the most dreaded  challenges 
facing thoracic aneurysm repairs regardless of the type 
of  surgical approach. The rate of stroke with thoracic 
aneurysm repair ranges from 3% to 5%.29,30 The potential 
etiologies include instrumentation of the aortic arch leading 
to  embolization or coverage of arch branches critical for 
cerebral perfusion. A critical knowledge of vertebrolateral 
dominance is crucial during planning and deployment. 
 Pre-emptive carotid subclavian bypass or transposition 
may be necessary in a nonemergent situation.40 In addition, 
activated clotting time (ACT) measurements should be taken 
at baseline and complete anticoagulation should be confirmed 
before any wire or catheter instrumentation of the aortic arch 
is attempted.
Paraplegia
In the FDA stent graft trials, spinal cord ischemia and paraple-
gia rates were diminished with endovascular repair compared 
to the open approach with a cumulative advantage of 6% ver-
sus 10%.33,34,41 Despite mild improvement in spinal cord isch-
emia, most experts recommend the routine use of spinal cord 
protective techniques for endovascular thoracic aneurysm 
repairs extending greater than 15 cm or those within 5 cm 
of the celiac axis. We have previously shown that with aggres-
sive protective measures, the incidence of spinal ischemia 
can approach 1%.42,43 Our paraplegia reduction strategies 
are multimodal and proactive. Management includes routine 
spinal fluid drainage (spinal fluid pressure <6 mmHg dur-
ing intraoperative aortic occlusion/exclusion), avoidance of 
hypotension (mean arterial pressure 90–100 mmHg during 
Table 1 Criteria for thoracoabdominal aneurysm intervention
Criterion Specific description
Aneurysm rupture As identified on radiographic studies or as 
clinically apparent
Acute dissection including ascending aorta or distal aorta with 
malperfusion of visceral end organs or lower 
extremities
Persistent  
symptomatic state
including localized pain, adjacent organ 
compression, and/or aortic valvular insufficiency
Rapid growth Defined as growth $1 cm/year
Absolute size Known connective tissue disorder 
– Ascending: .5.0 cm 
– Descending: .6.0 cm 
No known connective tissue disorder 
– Ascending: .5.5 cm 
– Descending: .6.5 cm
Notes: Specific criteria for intervention on thoracoabdominal aneurysms include 
the major categories of rupture, dissection, symptomatic nature, rapid growth, 
and standard progressive degenerative dilation. Adapted from Surg Clin North Am, 
89(4), elefteriades JA, Botta DM Jr, indications for the treatment of thoracic aortic 
aneurysms, 845–867, Copyright © 2009, with permission from elsevier.21
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and after reperfusion), and perioperative administration 
of the excitatory neurotransmitter inhibitor naloxone. 
Spinal drains are routinely left in place for 48 hours, unless 
clinical  parameters mandate longer drainage intervals. The 
spinal drains are capped when lower extremity motor func-
tion is consistently demonstrated. In addition to the inter-
ventions above, systemic steroids are administered shortly 
after anesthesia induction, and mannitol is given just before 
endovascular device deployment. The ability to stage repair 
has also been shown to effectively reduce paraplegia rates, 
presumably by allowing collateral pathways to mature and 
augment the spinal perfusion.27
Graft collapse
Graft collapse is perhaps the most catastrophic and poten-
tially lethal endovascular device failure.44 Often, this failure 
can result in rapid and potentially complete thoracic aortic 
occlusion, and has been associated with acute spinal isch-
emia, limb malperfusion, and renovisceral malperfusion 
syndromes.45,46 Potential factors contributing to this device 
failure include small aortic landing zone diameters, aggres-
sive oversizing, small radius curvature of the thoracic aorta, 
and “bird-beaking” of the proximal seal zone, as often seen 
in young patients with trauma-related aortic injuries.47–49 
A recent paper helped to elucidate and quantify the shear 
forces related to proximal malapposition (“bird-beaking”) 
of endografts, and provide the basis for patient-specific 
modeling to define at-risk endoprosthesis.50 If diagnosed and 
treated expeditiously, most at risk of collapsed grafts can be 
treated with high radial force interventions, including Palmaz 
stent placement.51
Access complications
Bilateral access is usually obtained and often requires a 
24-French profile, which equates to at least an 8 mm access 
diameter for safe delivery. Attention must be given to signifi-
cant atherosclerotic narrowing or calcification of the external 
iliac arteries to prevent damage to the vessel during delivery 
or removal. An additional option includes a small retroperi-
toneal cutdown to expose the common iliac artery to create a 
conduit. Other authors have advocated the use of controlled 
iliac rupture after the placement of an endoconduit.52
endoleaks
Endoleaks remain a challenging part of endovascular repair. 
Since their first descriptions in the late 1990s, the classifica-
tion remains largely unchanged.53,54
•	 Type Ia: Proximal seal failure.
•	 Type Ib: Distal seal failure.
•	 Type II: Retrograde branch vessel filling of sac.
•	 Type III: Failure of device component seal or graft 
fabric tears.
•	 Type IV: Graft porosity failure.
Thoracoabdominal endovascular repair remains a viable 
option for failed standard infrarenal repair. As Martin et al 
described, branched and fenestrated devices have a role in 
salvage of late failure of proximal type Ia endoleaks in 
infrarenal devices.55 As one would imagine, with the increas-
ing number of components required to complete total 
endovascular thoracoabdominal repairs, the incidence of 
 intercomponent failures increases, leading to higher rates of 
type III endoleaks. This has been estimated as high as 9.3% 
in recent series.56 The same group published their “lessons 
learned” in dealing with these complex secondary interven-
tions, including recommendations for technical changes and 
planning during the index operation.57
Total endovascular repair
Standard TeVAR
The current FDA-approved devices for TEVAR include the 
TAG graft and C-TAG (WL Gore, Flagstaff, AZ, USA), the 
Talent device (Medtronic, Santa Rosa, CA, USA), the Bolton 
Relay thoracic graft (Bolton Medical, Sunrise, FL, USA), 
and the Cook TX2 (Cook Medical, Bloomington, IN, USA). 
The proximal and distal landing zones must be accurately 
 measured. Most grafts require 10% to 20%  oversizing of the 
seal zone diameter. The distal landing zone is usually smaller 
than the proximal zone, which often results in the use of 
multiple grafts to adjust for this size difference or the use of 
a tapered graft. The tendency of the stent graft to follow the 
greater curvature of the aorta and the natural tortuosity of 
the vessel often leads to an underestimation of the coverage 
length. It is important to consider these factors when mea-
suring and planning deployment. Occasionally, Zone 2 or 
even more proximal landing zones are needed to accomplish 
adequate seal (Figure 2). Debranching  procedures are dis-
cussed in detail in the Hybrid Repair Section of this text.
It is generally recommended to have at least 2 cm of seal 
zone at either end of the graft to prevent migration. If there 
is severe angulation, calcification, or thrombus, the seal 
zone length may need to be extended. Accurate deployment 
positioning can be improved by performing aortography 
at an oblique projection of 40 to 60 degrees. Additionally, 
it is important to apply constant forward pressure during 
 deployment to allow the graft to conform along the outer 
curvature of the aorta and prevent graft jump. Completion 
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aneurysm, found that the 30-day mortality for elective TEVAR 
was 5.3%.31 The US multicenter trials also showed a significant 
improvement in mortality with endovascular repair at 2% 
versus 6% for open repair.32 Additional studies comparing 
elective endovascular versus open repairs have found overall 
mortality rates that were higher than those reported in the mul-
ticenter trials, yet still favored the endovascular approach.58,59 
In terms of ruptured descending thoracic aneurysms (DTAs), 
multiple meta-analysis found improved mortality with endo-
vascular repair ranging from 19% for TEVAR versus 33% for 
emergent open repair.58,60,61
Branched endografts
Total endovascular repair of thoracoabdominal aortic aneu-
rysms requires a strategy for preservation of any involved 
branched vessels, specifically the reno-visceral branches. For 
the most part, strategies have focused on creating a branched 
configuration in the endograft (Figure 4). One method to 
create branch points in an endograft is to use a combination 
of reinforced fenestrations and balloon-expandable covered 
stents. The proximal end of the covered stent is then flared 
at the site of the reinforced fenestrations to create a gasket 
seal. Another method is to use dedicated side branches 
incorporated into the endograft itself. The dedicated side 
Zone
0
Zone
1
Zone
2 Zone
3
Zone
4
Figure 2 Zones of the aortic arch. 
Notes: Proximal landing zone attachment sites for endovascular graft deployment. 
Reprinted from Surg Clin North Am, 89(4), Adams JD, Garcia LM, Kern JA, 
endovascular repair of the thoracic aorta, 895–912, Copyright © 2009, with 
permission from elsevier.93
Figure 3 Salvage TeVAR.
Notes: Salvage of failing prior open aortic transection repair using standard TeVAR technique. This 62-year-old patient had had a previous open aortic transection repair 
at the age of 18 years after a motor vehicle crash. Nearly 45 years later, he presented with acute onset left sided chest and back pain. On CTA he was found to have a 
pseudoaneurysmal contained leak at his previous anastomotic suture line (A). A single TeVAR device was deployed to cover the suture line pseudoaneurysm (B). His pain 
resolved and is event free 2 years later.
Abbreviations: TeVAR, thoracic endovascular aneurysm repair; CTA, computed tomographic angiography.
aortography will confirm exclusion of the aneurysm and 
allow evaluation for endoleak (Figure 3).
The combined EUROSTAR and UK thoracic endograft 
registries, which included 249 patients with degenerative 
Vascular Health and Risk Management 2014:10submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
498
Orr et al
branches are usually extended into the target vessels using 
self-expandable covered stents, which themselves are often 
reinforced with a bare stent to prevent kinking.
Greenberg et al reported on their experience using various 
combinations of these two approaches in 406 patients with 
thoracoabdominal aneurysms, as well as 227 patients with 
juxtarenal aneurysms.62 Reinforced fenestrations were the 
preferred method for renal branches given the angulation 
of these branches in reference to the aortic centerline. They 
were also the preferred method for visceral branch preserva-
tion in type IV thoracoabdominal aneurysms. Dedicated side 
branches were used for visceral preservation in type II and III 
aneurysms if the lumen of the aorta was greater than 35 mm in 
diameter at the visceral level and no dissection was present.
In this series, perioperative mortality was 1.8% for jux-
tarenal aneurysms, 2.3% for type IV aneurysms, 5.2% for 
type II and III aneurysms, and 12.5% for type I aneurysms. 
Late complications included rupture in five patients. In addi-
tion, branch vessel occlusion was seen in 2.3% of reinforced 
fenestrations at 15 months follow-up and in one side-arm 
branch. Postoperative sac behavior and endoleak rates were 
not reported.
In another large series by Haulon’s group, 89 patients with 
TAAs were treated using an endovascular approach similar 
to Greenberg’s.63 The TAAs were classified as type I in four 
patients, type II in 15 patients, type III in 25 patients, and 
type IV in 45 patients. To this series, reinforced  fenestrations 
were used for 123 renal arteries, 54 superior mesenteric 
arteries, and 15 celiac arteries. Dedicated side branches were 
used for 40 renal arteries, 33 superior mesenteric arteries, 
and 29 celiac arteries.
Technical success was achieved in 96.6% of the cases. The 
failures were related to target vessel loss in three patients. Two 
of these three patients had target vessel loss in more than one 
vessel, bringing the total to five target  vessels.  Perioperative 
mortality was 8.9%. There were no late ruptures in this 
cohort. At a median follow-up of 17 months, 22 endoleaks 
were identified (three type III and 19 type II). Sac behavior 
was not reported.
One of the disadvantages of this approach is the need for 
custom-designed grafts for each patient. Not only is the com-
mercial availability of these devices limited, but the time frame 
for manufacturing these devices is generally considered to be 
in the range of 6 to 8 weeks, which precludes urgent or emer-
gent cases. The t-Branch device (Cook Medical) was released 
to parts of the world in 2012 as a potential off-the-shelf design 
utilizing four downward-oriented renovisceral side branches. 
However, feasibility studies have suggested that this device 
can still only be used to treat between 63% to 83% of cases 
of thoracoabdominal aneurysms, even when combined with 
adjuvant procedures such as carotid-subclavian bypass or 
additional thoracic endografting.20,64 Regardless, Bosiers et al 
reported uniformally excellent results in their early experience 
of 15 patients treated with this device.65
Surgeon-modified devices have been proposed as an 
 alternative to commercially designed devices to further 
Figure 4 Branched endovascular devices.
Notes: The Zenith t-Branch device (A) (Cook Medical, Bloomington, iN, USA) is designed with four downward projecting branched access limbs. it deploys via a preloaded 
22-F delivery system. The superior mesenteric artery branch limb measures 8 mm wide by 18 mm long, and the celiac artery branch measures 8 mm wide by 21 mm long. 
The renal side branches measure 6 mm wide by 18 mm long. Above is an example of a complex aneurysm both before (B) and after (C) t-Branch endovascular treatment. 
Copyright © 2013 international Society of endovascular Specialists. Reproduced from Bosiers MJ, Bisdas T, Donas KP, Torsello G, Austermann M. early experience with the 
first commercially available off-the-shelf multibranched endograft (t-branch) in the treatment of thoracoabdominal aortic aneurysms. J Endovasc Ther. 2013;20(6):719–725.65
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increase patient applicability without undue manufacturing 
delay. However, the reported experience with these tech-
niques is quite limited at present. Ricotta et al reported their 
experience with surgeon-modified endografts in a cohort that 
included eight thoracoabdominal aneurysms.66 Reinforced 
fenestrations were used for all branches. There was one 
perioperative death in the group secondary to subarachnoid 
hemorrhage and one type III endoleak that required early 
reintervention. At mean follow-up of 9 months, no other 
type I or III endoleaks were observed. There was one type II 
endoleak. There were no cases of postoperative rupture or 
significant sac growth. Sac regression was observed in 64% 
of the total cohort. In a case report, Oderich et al recently 
described the technique of minicuff reinforced fenestrations 
using 3–5 mm lengths of smaller stent grafts to create some-
thing more akin to a dedicated side branch.67 The authors 
recommend this modification for TAAs with a larger luminal 
diameter in the visceral segment, specifically those in which 
the gap between the aortic endograft and the aortic wall is 
greater than 10 mm.
While these reports certainly attest to the feasibility of 
surgeon-modified branched grafts, the device planning and 
technical expertise for success in these cases should not be 
underestimated. Further, the effect of such modifications 
on the integrity of the parent device is unknown. Finally, 
depending on the locality, there are often medicolegal 
regulations for physician-modified devices that need to be 
addressed by the sponsoring institution prior to undertaking 
such a program.
Parallel and molded parallel endografts
Another popular option for branch vessel preservation 
 during complex aneurysm repair is to use parallel endografts 
 (Figure 5). Two recent publications summarized early results 
with parallel endografts.18,68 These papers included mostly jux-
tarenal pathologies, but did demonstrate a technical success rate 
of 98.9%.68 Additionally, they found a 97.8% patency rate at a 
mean follow-up interval of 9 months.18 While these techniques 
have been more commonly used for juxtarenal pathologies (ie, 
the so-called “chimney” or “snorkel” technique), the concept 
can be applied to TAAs by utilizing a standard endograft as 
the landing zone for the parallel endografts. This configuration 
has been referred to as the “sandwich” technique. The tech-
nique has been championed by Lobato and Camacho-Lobato, 
who recently reported a very large series of such cases that 
included 13 elective and two emergent TAA repairs.69 One of 
the elective thoracoabdominal cases was aborted when neither 
renal artery could be cannulated. In the remaining 14 cases, a 
total of five target vessels were sacrificed for various reasons, 
while 43 were successfully preserved. Perioperative mortality 
was 8% in the elective group, with the one death related to 
hepatic failure in a patient whose celiac artery was intentionally 
occluded after performing a viability test. The two emergent 
repairs were performed for rupture and both died in the post-
operative period from colonic infarction. One was secondary 
to an intraoperative SMA dissection and subsequent occlusion, 
while the other was apparently from hemodynamic instability. 
At mean follow-up of 16 months, there were no late target 
vessel losses. Intraoperatively, there was one type I and two 
type III endoleaks. However, they subsequently resolved. There 
was no late postoperative rupture or sac growth. Significant sac 
reduction was observed in all patients who had been followed 
for at least 24 months.
Figure 5 Parallel endografts.
Notes: Postoperative three-dimensional volume rendering of a type ii thoraco-
abdominal aneurysm treated with parallel endografts. The visceral stents were 
placed antegrade via left axillary access. The renal stents were placed retrograde via 
contralateral femoral access.
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While these results are far from perfect, they are 
comparable to what has been reported for more conventional 
branched configurations. Unfortunately, the small numbers 
preclude direct comparison between the two techniques. 
However, there are theoretical advantages and disadvantages 
that deserve consideration. The big advantage of parallel 
endografts is that they are completely modular, providing 
an off-the-shelf option for almost any anatomy without the 
need for device modification.
Another advantage is that the branch vessels are  cannulated 
prior to deployment of the aortic endoprosthesis. This advan-
tage can be quite important in three situations. The first is in 
tortuous anatomy, where alignment of a fenestration or side 
branch to the target vessel can be very difficult. The second 
is in small lumens, such as dissections, in which the aortic 
device may remain partially compressed. The third is when 
there is significant thrombus in the paravisceral aorta, placing 
the patient at risk for atheroembolization during deployment 
of the aortic endoprosthesis. It should be noted that at least 
one quarter of the perioperative deaths in Haulon’s series63 
of conventional branched grafts were from this etiology. 
In theory, these deaths may have been prevented if parallel 
endografts had been used and the renovisceral-covered stents 
deployed prior to the aortic endoprosthesis.
This distinction is a two-edged sword, though, because 
one of the disadvantages of parallel endografts is that 
all branch vessels must be cannulated prior to the aortic 
endoprosthesis. This requirement poses some logistical issues 
in terms of access. While Lobato described using bilateral 
axillobrachial access to accommodate the four renovisceral 
sheaths, our preference has been to use retrograde-covered 
stents in the renal arteries placed from sheaths in the contra-
lateral groin and unilateral (left) axillobrachial access for the 
sheaths used for the visceral stents.
The big disadvantage of parallel endografts, however, is 
the imperfect seal inherent to the technique. The side-by-side 
configuration leads to gutters along the parallel endografts, 
which can result in endoleaks and continued pressurization 
of the sac.
Many will contend that the gutters can be eliminated by 
oversizing the aortic stent so that it wraps around the branch 
stent. In reality, though, endografts are simply not designed 
to deploy in such a manner. Further, the effect of postbal-
looning is to make the devices more round. In vitro studies 
have shown that 40% oversizing of the aortic stent can best 
minimize (but still does not eliminate) the gutters along a 
single parallel branch stent. However, this approach also led 
to significant infolding, leaving the authors to recommend 
30% oversizing and accepting larger gutters.70 Using this 
amount of oversizing without achieving the prime objective 
is just not a practical strategy, let alone a feasible one, in 
larger aortas with multiple parallel endografts.
Alternatively, Lobato has suggested overlap lengths of at 
least 5 cm to induce thrombosis of the gutters. In our personal 
experience, though, we have seen persistent endoleaks with 
even 10 cm of overlap. Further, longer overlap lengths may 
affect patency rates and sometimes necessitate sacrifice of 
additional lumbar or intercostal vessels.
Our contention is that the gutters can be eliminated by 
molding the parallel graft into an eye-shape (as opposed to 
leaving it a round shape) so that the aortic graft can more 
easily conform to its exposed perimeter.71 We refer to this 
maneuver as the “eye of the tiger” technique (Figure 6).
For the “eye of the tiger” method, a balloon-expandable 
covered stent (iCAST; Atrium Medical Corporation, NH, 
USA) is deployed in the target branch vessel alongside a 
standard aortic endograft. The parallel portion of the iCAST 
is then postdilated by a factor of approximately 1.6 and the 
balloon is exchanged back for the original sized balloon. The 
iCAST is then crushed using a seating balloon in the aortic 
endograft to establish complete apposition of all perimeters. 
The central portion of the iCAST is then reinflated with the 
original sized balloon, creating an eye shape. Kissing bal-
loon angioplasty at low inflation pressures (∼2 atm) then 
completes the molding. The target length of overlap should 
be at least as much as that recommended for overlapping 
aortic devices.
Once the branch stent is molded into an eye-shape, it 
creates a luminal irregularity resembling that of a perfectly 
smooth atherosclerotic plaque, which is a shape that aortic 
endografts are much better designed to conform to.
In addition, the eye shape essentially represents two arcs 
intersecting at acute angles. The geometric term for this shape 
is a lens. If a lens is perfectly symmetrical, then by definition 
the two arcs are of equal length and radius. Therefore, the 
arc that the aortic endograft must conform to is exactly the 
same length as the arc that it would have had to conform to if 
the eye-shaped stent was not present. The only difference is 
that the arc is now convex rather than concave. The implica-
tion of this symmetry is that no additional oversizing of the 
aortic endograft is necessary. However, since symmetry is 
not always achieved, some oversizing is recommended.
Finally, it is important to note that we, like many others, 
have found that a seal can often be achieved with standard 
tube-shaped parallel endografts, especially when there is min-
imal potential outflow for any gutter leak. In these cases, we 
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usually test the waters with a standard parallel configuration, 
then only proceed with the “eye of the tiger” maneuver if 
there is persistent intraoperative type III endoleak.
Hybrid repair
The hybrid technique involves extra-anatomic debranching 
combined with staged or immediate endovascular aortic relin-
ing using covered aortic stent grafts (Figure 7). This combined 
approach was first performed in 1999 by Quiñones-Baldrich 
et al in a patient with a Crawford type IV TAA in order to 
avoid the morbidities associated with an open repair.72
The choice of open verses hybrid approach is dependent 
on the patient’s comorbidities, including the presence of 
severe COPD, the inability to tolerate a left thoracotomy, 
previous open thoracic operations, the presence of severe renal 
insufficiency, and cardiac impairment that would not tolerate 
proximal aortic clamping.73,74 By avoiding thoracotomy, extra-
corporeal perfusion, aortic cross-clamping, and single lung 
ventilation, the hybrid procedure has been suggested to have 
decreased mortality in high-risk patients.73,75 Other literature 
has suggested that the hybrid repair has no significant differ-
ence in outcomes when compared to open TAA repair.76–78
In approximately 20% of cases, the proximal seal zone 
can only be achieved by extending across the left subcla-
vian artery origin.79 Current Society for Vascular Surgery 
guidelines recommend preoperative left subclavian revas-
cularization in elective TEVAR and expectant management 
in acute settings, though this remains an area of debate.40 
The presence of a left dominant vertebrobasilar system or 
the existence of a left internal mammary coronary artery 
bypass graft are strong indications to consider pre-emptive 
carotid-subclavian bypass or transposition in the elective 
intervention. Others advocate for reactive revascularization 
only if arm claudication or subclavian steal occurs after rou-
tine covering of the origin. It should also be noted that the left 
subclavian can be an important input to the collateral network 
feeding the anterior spinal artery, and as such, if other inputs 
are diseased or excluded, direct revascularization should be 
strongly considered.
Figure 6 Molded TeVAR.
Notes: Postoperative computed tomography scan of a type V thoracoabdominal aneurysm treated with a single parallel graft to the celiac artery. The parallel graft has been 
molded to an eye-shape more proximally in the overlap zone to allow for perfect apposition of the multiple endoprostheses and elimination of any potential gutters (A). The 
parallel graft remains round more distally in the overlap zone near the origin of the celiac artery. Note the large gutters (B) that would have likely resulted in an endoleak if 
this covered stent had not been molded to an eye-shape more proximally.
Abbreviation: TeVAR, thoracic endovascular aneurysm repair.
Figure 7 Arch debranching.
Notes: Creation of a proximal landing zone can be accomplished with arch 
debranching. in this case, a left subclavian to left common carotid transposition 
(arrow) was created in anticipation of a Zone 2 proximal landing zone for subsequent 
TeVAR. Others have described the addition of carotid-carotid bypass to allow Zone 
1 proximal landing zone creation.
Abbreviation: TeVAR, thoracic endovascular aneurysm repair.
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For the majority of hybrid TAA repairs, the proximity 
of the celiac, SMA, and renal arteries to one another will 
mandate visceral bypasses. Selective celiac artery coverage 
is feasible, but recent studies found a bowel ischemia rate 
of approximately 6% and an endoleak rate of approximately 
16%.80,81 It is feasible to consider only mesenteric debranch-
ing in patients with pre-existing renal failure on dialysis. 
In general, the anatomy of the aneurysm will indicate the 
optimal origin for the retrograde bypass. For example, in a 
Crawford type I TAA, the native infrarenal aorta or a com-
mon iliac artery will provide a suitable graft origin. However, 
a Crawford type II or III TAA with contiguous dilation from 
the thoracic aorta throughout the common iliac vessels makes 
a hybrid repair challenging, and is best repaired with tradi-
tional open or total endovascular techniques.
The retrograde debranching is often performed using multi 
sidearm surgical grafts (Figure 8). Two of the limbs can be 
used to bypass to the right and left renal arteries, with the third 
limb being anastomosed to the SMA in an end-to-side  fashion. 
A jump graft is then created from this limb to the celiac axis. 
When creating the celiac artery anastomosis, the hepatic or 
splenic artery should be used because the exposure to the 
celiac bifurcation is difficult and leaves little room to ligate 
the main celiac trunk. It is necessary to ligate the origins of 
each debranched vessel to prevent a type II endoleak.
Staging of the hybrid repair is often necessary due to 
the long and technically demanding nature of the debranch-
ing procedure. This is especially true in the type II and III 
TAAs. The endovascular portion of the procedure should 
be performed as soon as the patient has recovered from 
the debranching procedure. It is advised that the staged 
 procedures be performed during the same admission given 
that interval aneurysm rupture has been reported when 
patients are discharged after debranching.75,82 Some have 
advocated placing a conduit limb (10 mm diameter) into 
the subcutaneous tissues of the lower abdominal wall. At the 
time of the secondary endovascular procedure, a small lower 
abdominal incision is made and the conduit limb is delivered 
Preop Abdominal
debranching
Post-
TEVAR
Post-
TEVAR
Figure 8 Multivisceral abdominal debranching.
Notes: Creation of a distal landing zone can be accomplished with abdominal debranching procedures. Celiac, SMA, and either or both renal arteries (arrows) can be 
debranched to facilitate TEVAR landing zones. Recent introduction of hybridized grafts has simplified this procedure.94 in addition, in those patients with poor access vessel 
diameter, a conduit limb can be tunneled into the anterior abdominal wall and left in place for future exposure, thrombectomy, and controlled access for later TeVAR 
introduction.
Abbreviations: Preop, preoperatively; SMA, superior mesenteric artery; TeVAR, thoracic endovascular aneurysm repair.
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and thrombectomized. It can then be used to cannulate and 
deploy the thoracic grafts.
There have been numerous case series evaluating the 
outcomes of hybrid TAA repairs. The Crawford type and 
emergency nature of these repairs must be taken into account 
when comparing outcome data. Overall, the 30-day mortality 
rates for the hybrid repair range from 0%–31%. The morbid-
ity ranges from 17%–56%, with a paraplegia risk of 0%–10% 
and graft occlusion rate ranging from 0%–13%.74,83–92 In one 
of the largest series to date (n=107), Drinkwater et al had the 
highest number of type II (n=45) and III (n=32) TAA with a 
mortality rate of 15% and morbidity of 38%.87 Concordant 
with the complexity of these repairs, they reported a rate of 
spinal ischemia of 12.1% and a rate of permanent paraplegia 
of 8.4%. Long-term dialysis was needed in 3.7% of patients, 
and 2.8% of the patients had an infarcted segment of bowel 
requiring resection. None of the cases in the Drinkwater series 
were emergent.87 The case series from Muehling’s group out 
of Germany had 16 patients and reported the highest rate 
of emergency cases (38%). They reported a mortality of 
31% and morbidity of 44%, with a paraplegia rate of 6%.90 
Quiñones-Baldrich’s group reported a series of 20 patients 
with no mortalities at 30 days, a mean follow-up of 16.6 
months, and an overall survival of 75%.84
The breadth of data indicates that the hybrid approach to 
TAA pathology is a reasonable option for high-risk patients. 
Patient selection and careful preoperative planning is crucial 
to the success of this approach.
Summary
As endovascular devices continue to mature, the breadth 
of patients that can be treated by total endovascular TAA 
repair continues to increase. In the absence of modular 
 off-the-shelf devices, these custom-designed branched 
devices are limited in application to elective cases. However, 
as these technologies improve and operator learning curves 
advance, we can expect to treat an increasing population 
with total endovascular techniques. Hybrid options remain a 
viable alternative in those patients who require creation of a 
definitive landing zone.
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